Study on myxomycetes as a new source of bioactive natural products

Yakugaku Zasshi

Volumn 127, Issue 9, 2007, Pages 1369-1381

  Ishibashi, Masami ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Myxomycetes; Natural products; True slime mold

Indexed keywords

ALDEHYDE; CYCLOANTHRANILYLPROLINE; DIBENZOFURAN; LACTONE; NAPHTHOQUINONE; NATURAL PRODUCT; PEPTIDE; POLYENE; PROLINE DERIVATIVE; PROTEIN TYROSINE KINASE INHIBITOR; PYRROLOIMINOQUINONE DERIVATIVE; STEROL; TRITERPENOID; UNCLASSIFIED DRUG;

BIOLOGICAL ACTIVITY; CHEMISTRY; FUNGAL SPORE GERMINATION; FUNGUS CULTURE; ISOLATION PROCEDURE; JAPAN; LABORATORY TEST; MYXOMYCETES; NONHUMAN; PLASMODIUM; REVIEW;

ANIMALS; BENZOFURANS; DRUG DESIGN; GLYCOSIDES; LACTONES; MYXOMYCETES; NAPHTHOQUINONES; POLYENES; PROLINE; PYRROLOIMINOQUINONES; STEROLS;

EID: 34548427846     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.127.1369     Document Type: Review

References (36)

1. Steglich W., Pure Appl. Chem., 61, 281-288 (1989).
2. Hashimoto T., Yasuda A., Akazawa K., Takaoka S., Tori M., Asakawa Y., Tetrahedron Lett., 35, 2559-2560 (1994).
3. Ishibashi M., Biosci. Ind., 63, 467-470 (2005).
4. Ishibashi M., Med. Chem., 1, 575-590 (2005).
5. Ishibashi M., Yuki Gosei Kagaku Kyokai-Shi, 61, 152-163 (2003).
6. Ishibashi M., "Studies in Natural Products Chemistry", Vol. 29, ed. by Atta-ur-Rahman, Elsevier Science, Amsterdam, 2003, pp. 223-262.
7. Ishibashi M., Iwasaki T., Imai S., Sakamoto S., Yamaguchi K., Ito A., J. Nat. Prod., 64, 108-110 (2001).
8. Radisky D. C., Radisky E. S., Barrows L. R., Copp B. R., Kramer R. A., Ireland C. M., J. Am. Chem. Soc., 115, 1632-1638 (1993).
9. Misono Y., Ishibashi M., Ito A., Chem. Pharm. Bull., 51, 612-613 (2003).
10. Nakatani S., Kiyota M., Matsumoto J., Ishibashi M., Biochem. Syst. Ecol., 33, 323-325 (2005).
11. Schmidt E.W., Harper M. K., Faulkner D. J., J. Nat. Prod., 58, 1861-1867 (1995).
12. Misono Y., Ito A., Matsumoto J., Sakamoto S., Yamaguchi K., Ishibashi M., Tetrahedron Lett., 44, 4479-4481 (2003).
13. Nakatani S., Kamata K., Sato M., Onuki H., Hirota H., Matsumoto J., Ishibashi M., Tetrahedron Lett., 46, 267-271 (2005).
14. Hanazawa S., Kimura N., Arai M. A., Ishibashi M., Abstracts of Papers, the 127th Annual Meeting of the Pharmaceutical Society of Japan, Toyama, March 2007, No. 4, p. 6.
15. Naoe A., Ishibashi M., Yamamoto Y., Tetrahedron, 59, 3433-3435 (2003).
16. Iwata D., Ishibashi M., Yamamoto Y., J. Nat. Prod., 66, 1611-1612 (2003).
17. Ishikawa Y., Ishibashi M., Yamamoto Y., Hayashi M., Komiyama K., Chem. Pharm. Bull., 50, 1126-1127 (2002).
18. Misono Y., Ishikawa Y., Yamamoto Y., Hayashi M., Komiyama K., Ishibashi M., J. Nat. Prod., 66, 999-1001 (2003).
19. Misono Y., Nakatani S., Kamata K., Ishibashi M., Abstracts of Papers, the 50th Annual Meeting of the Japanese Society of Pharmacognosy, Tokyo, September 2003, p. 68.
20. Nakatani S., Naoe A., Yamamoto Y., Yamauchi T., Yamaguchi N., Ishibashi M., Bioorg. Med. Chem. Lett., 13, 2879-2881 (2003).
21. Kamata K., Kiyota M., Naoe A., Nakatani S., Yamamoto Y., Hayashi M., Komiyama K., Yamori T., Ishibashi M., Chem. Pharm. Bull., 53, 594-597 (2005).
22. Kamata K., Suetsugu T., Kato Y., Hosoya T., Sonoda T., Ohtsuki T., Ishibashi M., Abstracts of Papers, the 15th Symposium on the Development and Application of Naturally Occurring Drug Materials, Tokyo, November 2005, pp. 258-261.
23. Kaniwa K., Arai M. A., Li X., Ishibashi M., Bioorg. Med. Chem. Lett. 17, 4254-4257 (2007).
24. Hosoya T., Yamamoto Y., Uehara Y., Hayashi M., Komiyama K., Ishibashi M., Bioorg. Med. Chem. Lett., 15, 2776-2780 (2005).
25. Kamata K., Suetsugu T., Yamamoto Y., Hayashi M., Komiyama K., Ishibashi M., J. Nat. Prod., 69, 1252-1254 (2006).
26. Hosoya T., Arai M. A., Ishibashi M., Abstracts of Papers, the 127th Annual Meeting of the Pharmaceutical Society of Japan, Toyama, March 2007, No. 4, p. 126.
27. Li X., Ohtsuki T., Ishibashi M., Abstracts of Papers, the 127th Annual Meeting of the Pharmaceutical Society of Japan, Toyama, March 2007, No. 4, p. 126.
28. Nakatani S., Yamamoto Y., Hayashi M., Komiyama K., Ishibashi M., Chem. Pharm. Bull., 52, 368-370 (2004).
29. Hasegawa H., Komiyama K., Isihibashi M., Hayashi M., Sunazuka T., Abstracts of Papers, the 10th Annual Meeting of Japanese Association for Molecular Target Therapy of Cancer, Tokyo, June 2006, p. 100.
30. Hosoya T., Kato Y., Yamamoto Y., Hayashi M., Komiyama K., Ishibashi M., Heterocycles, 69, 463-468 (2006).
31. Hirose Y., Hasegawa S., Ozaki N., Tetrahedron Lett., 24, 1535-1538 (1983).
32. Shibuya T., Phytochemisty, 12, 4289-4294 (1992).
33. Kamata K., Onuki H., Hirota H., Yamamoto Y., Hayashi M., Komiyama K., Sato M., Ishibashi M., Tetrahedron, 60, 9835-9839 (2004).
34. Kaniwa K., Ohtsuki T., Yamamoto Y., Ishibashi M., Tetrahedron Lett., 47, 1505-1508 (2006).
35. Kaniwa K., Ohtsuki T., Sonoda T., Yamamoto Y., Hayashi M., Komiyama K., Ishibashi M., Tetrahedron Lett., 47, 4351-4354 (2006).
36. Watanabe K., Ohtsuki T., Yamamoto Y., Ishibashi M., Heterocycles 71, 1807-1814 (2007).